BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 30106309)

  • 1. Lactate transporters as therapeutic targets in cancer and inflammatory diseases.
    Pucino V; Cucchi D; Mauro C
    Expert Opin Ther Targets; 2018 Sep; 22(9):735-743. PubMed ID: 30106309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting lactate metabolism for cancer therapeutics.
    Doherty JR; Cleveland JL
    J Clin Invest; 2013 Sep; 123(9):3685-92. PubMed ID: 23999443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting monocarboxylate transporters (MCTs) in cancer: How close are we to the clinics?
    Singh M; Afonso J; Sharma D; Gupta R; Kumar V; Rani R; Baltazar F; Kumar V
    Semin Cancer Biol; 2023 May; 90():1-14. PubMed ID: 36706846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of monocarboxylate transporters in head and neck squamous cell carcinoma.
    Chandel V; Maru S; Kumar A; Kumar A; Sharma A; Rathi B; Kumar D
    Life Sci; 2021 Aug; 279():119709. PubMed ID: 34102188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
    Pertega-Gomes N; Felisbino S; Massie CE; Vizcaino JR; Coelho R; Sandi C; Simoes-Sousa S; Jurmeister S; Ramos-Montoya A; Asim M; Tran M; Oliveira E; Lobo da Cunha A; Maximo V; Baltazar F; Neal DE; Fryer LG
    J Pathol; 2015 Aug; 236(4):517-30. PubMed ID: 25875424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments.
    Draoui N; Feron O
    Dis Model Mech; 2011 Nov; 4(6):727-32. PubMed ID: 22065843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lactate transporters in the context of prostate cancer metabolism: what do we know?
    Pértega-Gomes N; Baltazar F
    Int J Mol Sci; 2014 Oct; 15(10):18333-48. PubMed ID: 25314297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments of human monocarboxylate transporter (hMCT) inhibitors as anticancer agents.
    Wu P; Zhou Y; Guo Y; Zhang SL; Tam KY
    Drug Discov Today; 2021 Mar; 26(3):836-844. PubMed ID: 33450176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarboxylate transporters in the brain and in cancer.
    Pérez-Escuredo J; Van Hée VF; Sboarina M; Falces J; Payen VL; Pellerin L; Sonveaux P
    Biochim Biophys Acta; 2016 Oct; 1863(10):2481-97. PubMed ID: 26993058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactate and Lactate Transporters as Key Players in the Maintenance of the Warburg Effect.
    Pereira-Nunes A; Afonso J; Granja S; Baltazar F
    Adv Exp Med Biol; 2020; 1219():51-74. PubMed ID: 32130693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SLC16A family of monocarboxylate transporters (MCTs)--physiology and function in cellular metabolism, pH homeostasis, and fluid transport.
    Adijanto J; Philp NJ
    Curr Top Membr; 2012; 70():275-311. PubMed ID: 23177990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monocarboxylate transporters: past, present, and future.
    Merezhinskaya N; Fishbein WN
    Histol Histopathol; 2009 Feb; 24(2):243-64. PubMed ID: 19085840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactate transport and signaling in the brain: potential therapeutic targets and roles in body-brain interaction.
    Bergersen LH
    J Cereb Blood Flow Metab; 2015 Feb; 35(2):176-85. PubMed ID: 25425080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate: Fueling the fire starter.
    Certo M; Marone G; de Paulis A; Mauro C; Pucino V
    Wiley Interdiscip Rev Syst Biol Med; 2020 May; 12(3):e1474. PubMed ID: 31840439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters.
    Marchiq I; Pouysségur J
    J Mol Med (Berl); 2016 Feb; 94(2):155-71. PubMed ID: 26099350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocarboxylate transporters in cancer.
    Payen VL; Mina E; Van Hée VF; Porporato PE; Sonveaux P
    Mol Metab; 2020 Mar; 33():48-66. PubMed ID: 31395464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting lactate production and efflux in prostate cancer.
    Pereira-Nunes A; Simões-Sousa S; Pinheiro C; Miranda-Gonçalves V; Granja S; Baltazar F
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165894. PubMed ID: 32650130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring Lactate Dynamics in Individual Macrophages with a Genetically Encoded Probe.
    Baeza-Lehnert F; Flores CA; Guequén A; Barros LF
    Methods Mol Biol; 2020; 2184():19-30. PubMed ID: 32808215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor metabolism of lactate: the influence and therapeutic potential for MCT and CD147 regulation.
    Kennedy KM; Dewhirst MW
    Future Oncol; 2010 Jan; 6(1):127-48. PubMed ID: 20021214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.
    Ganapathy V; Thangaraju M; Prasad PD
    Pharmacol Ther; 2009 Jan; 121(1):29-40. PubMed ID: 18992769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.